Fig. 9From: Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulationImprovement in “pattern VEP” according to study timepoints (T0, T2) in the eye treated with combination of WJ-MSC and rEMS (Table 1, patient 6: left eye). a Before application, P100 latency 139 ms, P100 amplitude 2.9 mV b at 4th month, P100 latency 106 ms, P100 amplitude 6.3 mVBack to article page